Avedro acquires assests from IROC Innocross AG

Article

Avedro Inc. recently announced that it has purchased the assets of IROC Innocross AG, of Zug, Switzerland.

Boston-Avedro Inc. recently announced that it has purchased the assets of IROC Innocross AG, of Zug, Switzerland.

FDA seeking more info on Avedro’s corneal cross-linking NDA

IROC Innocross was the first company to commercialize a cross-linking device for the treatment of keratoconus and other corneal pathologies.

With this acquisition, Avedro’s platform of cross-linking technology now covers the entire spectrum of corneal cross-linking procedures, from treating corneal pathology with our UV-X devices and MedioCROSS riboflavin–to enhancing LASIK outcomes with our KXL System andVibeX riboflavin–to developing non-invasive refractive procedures with our advanced KXL II System.

Avedro will continue to work with key IROC Innocross suppliers MDP Solutions in Switzerland and Solnovis in Germany to ensure product supply and development.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
© 2025 MJH Life Sciences

All rights reserved.